Company / Operating Margin
Ginkgo Bioworks Holdings, Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-185.3%
FY2025
5-year range
-582.6% / -185.3%
FY2021-FY2025
Trend
+24.8%
vs FY2024
Sector context
#95 of 133
Health Care
What the data says
At -185.3%, Ginkgo Bioworks Holdings, Inc.'s operating margin ranks #95 of 133 in the Health Care sector. Operating Margin has increased for 4 consecutive years, from -582.6% in FY2021 to -185.3% in FY2025.
Based on SEC 10-K filings.
-185.3% in FY2025 with a 3-year CAGR of +277.1%.
Improved from -343.8% to -185.3% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +277.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#95 of 133 in Health CareTop 71% of 133This company -185.3% Sector average -914.0%
▼
+79.7% above sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s operating margin has grown for 4 consecutive years.
- In FY2025, operating margin increased 24.8% year-over-year.
- Currently 728.7pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -185.3% | +24.8% |
| FY2024 | -246.5% | +28.3% |
| FY2023 | -343.8% | +25.7% |
| FY2022 | -462.4% | +20.6% |
| FY2021 | -582.6% | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026